GlassScriptPhysician profile
Stella W Wise
NPI 1578922233
$2,490.04
in general payments reported to CMS, 2019-2025
23 companies · $16.16 in 2025
The $16.16 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,280 · 2022: $986 · 2023: $159 · 2024: $49.69 · 2025: $16.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $224.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $444.25 | 2021-2023 | Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $402.40 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $399.07 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $241.51 | 2021-2023 | Dupixent |
| Jazz Pharmaceuticals INC. | $170.44 | 2021-2022 | |
| Mylan Specialty L.P. | $130.54 | 2021-2022 | |
| Genzyme Corporation | $95.21 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $70.50 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $68.98 | 2022 | |
| Grifols USA, LLC | $64.64 | 2021-2022 | |
| United Therapeutics Corporation | $62.47 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $53.79 | 2021-2022 | |
| Intuitive Surgical, INC. | $49.69 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $45.84 | 2022 | |
| Amgen INC. | $31.41 | 2023-2025 | Tezspire |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $31.40 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.41 | 2021 | |
| Abbvie INC. | $22.21 | 2022 | |
| Genentech USA, INC. | $20.52 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $20.39 | 2022 | |
| Tactile Systems Technology INC | $17.50 | 2022 | |
| Philips North America LLC | $13.78 | 2022 | |
| Advanced Respiratory, INC | $11.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stella Wise listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.